Nidan Laboratories and Healthcare (NSE:NIDAN) Debt-to-Equity : 0.19 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Nidan Laboratories and Healthcare Debt-to-Equity?

Nidan Laboratories and Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹81.4 Mil. Nidan Laboratories and Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹42.9 Mil. Nidan Laboratories and Healthcare's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹662.1 Mil. Nidan Laboratories and Healthcare's debt to equity for the quarter that ended in Mar. 2024 was 0.19.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Nidan Laboratories and Healthcare's Debt-to-Equity or its related term are showing as below:

NSE:NIDAN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.16 Med: 1.57 Max: 3.12
Current: 0.19

During the past 6 years, the highest Debt-to-Equity Ratio of Nidan Laboratories and Healthcare was 3.12. The lowest was 0.16. And the median was 1.57.

NSE:NIDAN's Debt-to-Equity is ranked better than
57.07% of 191 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs NSE:NIDAN: 0.19

Nidan Laboratories and Healthcare Debt-to-Equity Historical Data

The historical data trend for Nidan Laboratories and Healthcare's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nidan Laboratories and Healthcare Debt-to-Equity Chart

Nidan Laboratories and Healthcare Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

3.12

2.85

0.29

0.16

0.19

Nidan Laboratories and Healthcare Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial			N/A	0.29	0.25	0.16	0.19

Competitive Comparison of Nidan Laboratories and Healthcare's Debt-to-Equity

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nidan Laboratories and Healthcare's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Nidan Laboratories and Healthcare Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Nidan Laboratories and Healthcare's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(81.408	+	42.938)	/	662.061
	=	0.19

Nidan Laboratories and Healthcare's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(81.408	+	42.938)	/	662.061
	=	0.19

Nidan Laboratories and Healthcare (NSE:NIDAN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Nidan Laboratories and Healthcare Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Nidan Laboratories and Healthcare's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nidan Laboratories and Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303

Website

https://www.nidanhealthcare.co.in

Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.

Nidan Laboratories and Healthcare Headlines

No Headlines